EAGLE PHARMACEUTICALS, INC. Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EAGLE PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EAGLE PHARMACEUTICALS, INC. for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 42.40 | 137,200 | 5,817,280 | 137,200 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Grant | A | 0.00 | 61,300 | 0 | 1,579,690 | 1.5 M to 1.6 M (+4.04 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | RATOFF STEVEN B | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Option Exercise | A | 42.40 | 46,600 | 1,975,840 | 46,600 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Grant | A | 0.00 | 20,900 | 0 | 31,008 | 10.1 K to 31 K (+206.77 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Payment of Exercise | F | 41.33 | 858 | 35,461 | 10,108 | 11 K to 10.1 K (-7.82 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 42.40 | 43,200 | 1,831,680 | 43,200 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Grant | A | 0.00 | 19,300 | 0 | 26,400 | 7.1 K to 26.4 K (+271.83 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Payment of Exercise | F | 41.33 | 600 | 24,798 | 7,100 | 7.7 K to 7.1 K (-7.79 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Option Exercise | A | 42.40 | 42,500 | 1,802,000 | 42,500 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Grant | A | 0.00 | 19,000 | 0 | 27,229 | 8.2 K to 27.2 K (+230.89 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Payment of Exercise | F | 41.33 | 771 | 31,865 | 8,229 | 9 K to 8.2 K (-8.57 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Graves Michael | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Glenning Robert | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Edlin Richard A. | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
| Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 40.57 | 302 | 12,252 | 1,518,390 | 1.5 M to 1.5 M (-0.02 %) |
| Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 39.70 | 5,670 | 225,099 | 1,518,692 | 1.5 M to 1.5 M (-0.37 %) |
| Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 39.04 | 10,597 | 413,707 | 1,524,362 | 1.5 M to 1.5 M (-0.69 %) |
| Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 40.03 | 8,500 | 340,255 | 1,534,959 | 1.5 M to 1.5 M (-0.55 %) |
| Jan 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 39.30 | 6,500 | 255,450 | 1,543,459 | 1.5 M to 1.5 M (-0.42 %) |